Tools chosen: polymarket_direct claude_news gdelt_news congress_bills polymarket_related kalshi_related wikipedia code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a Polymarket question about a discrete diplomatic/legal milestone: a U.S.–Saudi Section 123 peaceful nuclear cooperation agreement entering into force by end-2026. Entry into force requires negotiation completion, signature, presidential submission to Congress, and a statutory 90-day-of-continuous-session review period, so the key research is the current negotiation status (post-Nov 2025 MBS visit MOU) and whether the calendar plus unresolved enrichment/ENR and Israel-normalization sticking points allow completion in 2026.

# Current state The U.S.–Saudi 123 Agreement text (plus bilateral safeguards agreement) was signed on 2026-07-22, but as of 2026-08-06 it had **not yet been formally submitted to Congress** with the required Nuclear Proliferation Assessment Statement — meaning the mandatory 90-continuous-session-day statutory review clock has not started. Entry into force also faces a fresh political obstacle: hours after signing, Trump publicly conditioned the deal on Saudi Arabia joining the Abraham Accords, which Riyadh has said it will not do "for now." # Timeline of key events - 2025-11: "Joint Declaration on the Completion of Negotiations on Civil Nuclear Energy Cooperation" signed during MBS's White House visit (confirmed — energy.gov, congress.gov). - 2026-03-26: Sen. Markey introduces S.4243, "No Nuclear Weapons for Saudi Arabia Act of 2026," referred to Senate Foreign Relations Committee (confirmed — congress.gov). - 2026-07-22: U.S. (Energy Sec. Wright) and Saudi Arabia (Prince Abdulaziz bin Salman) sign the 123 Agreement and an accompanying bilateral safeguards agreement (confirmed — DOE, CNN, Al Jazeera, multiple outlets). - 2026-07-23: Trump states on Truth Social that the deal hinges on Saudi Arabia normalizing relations with Israel; Saudi Arabia has previously rejected near-term Abraham Accords accession (reported — NPR, Axios). - 2026-07-24: Reports that Trump was unhappy with the Energy Secretary over how the deal was handled (reported — news.am). - 2026-08-06: Sen. Shaheen (SFRC Ranking Member) states the agreement has not yet been formally submitted to Congress or briefed in detail (confirmed — foreign.senate.gov). - 2026-08-07: Arms Control Association confirms the deal does not require Saudi adoption of the IAEA Additional Protocol, despite bipartisan Senate calls for "gold standard" terms (confirmed — armscontrol.org). # Event Will the bilateral U.S.–Saudi Section 123 nuclear cooperation agreement legally enter into force between the two governments by Dec 31, 2026? # Outcomes to forecast Yes / No # Kalshi market anchor No direct kalshi_direct price was returned in this research pull. A market-data feed tagged "polymarket_direct" carrying this event's exact ticker shows **YES ≈ 23%**, up +2.5% (7d) and +6% (30d), on modest volume (~$30K total, 31 data points), with a historical range of 15.5%–77.5% (implying a much higher probability priced in earlier, before the Israel-linkage complication emerged). Treat 23% as the best available consensus anchor absent a distinct Kalshi print. # Sub-question answers 1. **Text initialed/signed vs. MOU?** A binding 123 Agreement text plus safeguards agreement was signed 2026-07-22 — beyond MOU stage (DOE, CNN). 2. **Statutory steps/timing?** 90 continuous session days (30-day committee + 60-day full Congress) required after formal submission; code-execution analysis puts the latest submission date compatible with 2026 EIF at roughly May–July 2026 — already passed or barely met, and submission still hadn't occurred as of Aug 6. 3. **Enrichment dispute/Additional Protocol?** Unresolved: agreement reportedly allows a path to Saudi domestic enrichment via a joint feasibility study rather than an outright ban; Arms Control Association confirms the deal does NOT require the IAEA Additional Protocol, contrary to "gold standard" demands from Sens. Risch/Shaheen. 4. **Israel normalization linkage?** Reinstated, not dropped — Trump publicly tied the deal to Abraham Accords accession on 2026-07-23; Saudi Arabia has said it won't join "for now" (NPR, CFR calls this a "poison pill"). 5. **Congressional appetite for disapproval?** Active: S.4243 (Markey) "No Nuclear Weapons for Saudi Arabia Act" pending in SFRC since March 2026; bipartisan concern from Risch and Shaheen over lack of gold-standard terms. 6. **Historical base rate?** 123 agreements historically take ~7–48 months from signature to EIF (median ~16 months); no precedent case achieved EIF in ~5 months (code_execution analysis). 7. **Polymarket/related markets?** This event's own market at 23% (declining from historical highs of 77.5%). Related Kalshi market "Israel-Saudi normalize during Trump's term" trades at 28% (down 10-12% recently) — reinforcing that normalization (a precondition per Trump) is itself uncertain. # Key facts (high-confidence, factual) 1. [DOE, congress.gov] 123 Agreement + safeguards agreement signed 2026-07-22. 2. [foreign.senate.gov] Not yet formally submitted to Congress as of 2026-08-06. 3. [armscontrol.org] No IAEA Additional Protocol requirement in the deal. 4. [NPR/Axios] Trump linked entry into force to Saudi-Israel normalization (2026-07-23). 5. [congress.gov] S.4243 disapproval-oriented bill pending since 2026-03-26. # Cross-market signals - Kalshi related: "Israel–Saudi normalize during Trump's term" at 28% (falling); "US builds nuclear-powered military data center before 2030" at 46%. - Polymarket (own ticker): 23% YES, down from a 77.5% historical high — sharp repricing after the Israel-linkage news broke. - No dedicated sportsbook markets. # Analyst opinions and speculation - CFR: deal's near-term future "in doubt," Trump's Abraham Accords linkage a "poison pill" for Hill review. - Arms Control Association's Kelsey Davenport: deal "sets a terrible precedent" by dropping enrichment/reprocessing restrictions — fuels disapproval-resolution risk. - CFR flags midterm-election timing risk: review could bleed into a new Congress in 2027. # Directional lean per outcome - **Yes**: Signature already achieved (unusual progress); administration has incentive to push quickly; no submission yet reported blocked outright. - **No**: Submission not yet made (as of Aug 6, ~5 months from year-end); calendar math makes 90-continuous-session-day completion by Dec 31 very tight to implausible; unresolved Israel-normalization precondition Saudi rejects; active disapproval bill; historical precedent shows no comparable case moving this fast from signature to EIF. # Gaps / unknowns - Exact/actual submission date to Congress (still pending as of latest data, 2026-08-07). - Whether Trump's Israel-linkage is a hard precondition or negotiating rhetoric. - Congressional session calendar specifics (recesses) affecting the 90-day count. - No confirmed Kalshi-direct price snapshot in this research batch. # Calibration anchors - Polymarket/ticker-matched price: 23% YES (trending up but far below historical 77.5% high). - Code-execution model estimate: ~10–20% unconditional probability of 2026 EIF given "signed but not yet submitted" status. - Historical 123-agreement base rate: median 16 months signature-to-force; no precedent under ~7 months.

1. Both forecasters converge tightly (10% and 14%) despite explicitly citing a code-execution model range of "10-20%" — neither explores the upper half of that range or explains why they land near the bottom, understating genuine uncertainty about submission timing that could still occur soon. 2. Both treat Trump's Israel-linkage as a near-hard precondition pointing strongly toward No, but the brief notes unknowns about "whether Trump's Israel-linkage is a hard precondition or negotiating rhetoric" — Trump has a history of using maximalist rhetoric that later softens or is quietly dropped, and neither forecast seriously weights a scenario where the administration proceeds without actual Saudi accession. 3. Neither forecast addresses the specific statutory mechanics of what happens if the deal enters force via a different procedural path (e.g., some 123 agreements can enter into force via joint resolution or executive/administrative certification without needing full disapproval-review completion in edge cases) — both assume the standard 90-day clock is the only pathway without discussing possible administration workarounds or expedited processes given political pressure. 4. Both undercut the market anchor (23%) by similar margins (13pp and 9pp) using identical reasoning about "thin market underweighting session-day arithmetic," but neither considers that the Polymarket price already fell sharply from 77.5% specifically in response to the Israel-linkage news — meaning the market has already priced in much of what the forecasters cite as their reason for going lower, raising the question of whether an additional ~10pp discount is justified or double-counts the same information. 5. Neither forecaster explicitly addresses the disapproval-resolution risk distinctly from the timing risk — S.4243 and bipartisan gold-standard concerns are cited as compounding evidence for No, but if Congress simply runs out the clock without ever voting the deal down, that is a different failure mode (procedural default to non-entry) versus affirmative disapproval, and the brief doesn't clarify which failure mode is more likely, which affects tail scenarios (e.g., a late-year rush to formally submit and start the clock even if completion is impossible by Dec 31). 6. Both forecasts treat "administration incentive to push quickly" as a minor Yes-side consideration but don't quantify what a rushed submission (e.g., September) combined with an aggressive session calendar could imply for reaching threshold by Dec 31 — the calendar math is asserted as "very tight to implausible" but no forecaster actually works through session-day counting to show whether even an immediate submission could meet the deadline.

9% (73% confidence)

Yes: 9% No: 91%

The binding constraint is arithmetic, not politics: a 123 agreement cannot legally enter into force until 90 continuous session days elapse after formal submission with an NPAS, and as of Aug 6, 2026 submission had not occurred. Ninety continuous session days typically consumes 5-7 calendar months, and an election-year calendar (August recess, an extended October-November campaign recess, lame-duck compression) makes completion by Dec 31 essentially impossible even with an immediate September submission — this alone justifies going below the thin ~23% ticker price, and it is not double-counting the Israel-linkage repricing since it is an independent mechanical obstacle. The critique's suggested workarounds (joint resolution of approval, expedited/administrative paths) are theoretically available but have no modern precedent for a 123 agreement and would require affirmative congressional action at a moment when bipartisan senators are demanding gold-standard/Additional Protocol terms the deal lacks, with S.4243 pending. Trump's Abraham Accords linkage may well be soft rhetoric, but softening it only removes a secondary barrier while the session-day clock remains binding. I therefore land slightly below both forecasters' midpoint and well below the market, reserving ~9% for the tails: a rushed submission plus an unprecedented legislative approval vehicle, or reporting errors about the submission date.

Total pipeline time: 223.1s